Zota Health Care Ltd

Zota Health Care Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Zota Health Care Ltd

₹ 485 -0.29%
26 Apr - close price
Company website NSE : ZOTA
About

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]

Key Points

Business segments
Domestic sales (49% of FY21 revenue)[1] The is the oldest division and involves direct distribution of generic drugs, OTC products, and other pharmaceutical products through Company’s distribution network across India. Co. has 1050+ distributors across India and 3000+ products in its portfolio.

Website NSE
  • Market Cap ₹ 1,254 Cr.
  • Current Price ₹ 485
  • High / Low ₹ 555 / 272
  • Stock P/E
  • Book Value ₹ 39.5
  • Dividend Yield 0.21 %
  • ROCE -2.32 %
  • ROE -7.42 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 91.2 to 72.9 days.

Cons

  • Stock is trading at 12.3 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 0.63% over last 3 years.
  • Promoter holding has decreased over last 3 years: -3.80%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
30.48 30.59 33.44 35.39 31.02 31.34 29.19 38.95 34.97 36.85 38.65 45.27 46.93
31.67 30.79 28.55 30.54 26.03 31.27 27.74 34.12 34.95 35.82 37.37 40.84 43.59
Operating Profit -1.19 -0.20 4.89 4.85 4.99 0.07 1.45 4.83 0.02 1.03 1.28 4.43 3.34
OPM % -3.90% -0.65% 14.62% 13.70% 16.09% 0.22% 4.97% 12.40% 0.06% 2.80% 3.31% 9.79% 7.12%
0.57 0.25 0.30 0.18 0.34 0.81 0.47 0.84 0.62 0.56 0.15 0.40 0.15
Interest 0.03 0.05 0.01 0.01 0.01 0.29 0.38 0.66 0.71 0.81 0.83 1.14 1.14
Depreciation 0.80 0.86 0.62 0.68 0.78 1.58 1.91 2.87 3.30 3.88 3.41 4.80 5.08
Profit before tax -1.45 -0.86 4.56 4.34 4.54 -0.99 -0.37 2.14 -3.37 -3.10 -2.81 -1.11 -2.73
Tax % 30.34% 15.12% 26.10% 25.81% 26.21% -1.01% -118.92% 57.94% 4.15% 14.84% -1.07% -48.65% -7.33%
-1.01 -0.73 3.37 3.21 3.34 -1.01 -0.82 0.91 -3.23 -2.63 -2.84 -1.65 -2.94
EPS in Rs -0.41 -0.30 1.37 1.28 1.33 -0.40 -0.33 0.36 -1.28 -1.05 -1.13 -0.64 -1.14
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2014 Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
25 38 50 56 85 95 106 131 139 168
21 33 43 47 77 90 105 116 132 158
Operating Profit 4 5 6 8 8 5 1 15 7 10
OPM % 14% 13% 13% 15% 9% 5% 1% 11% 5% 6%
0 0 0 0 2 2 2 2 2 1
Interest 0 1 1 1 0 0 0 0 3 4
Depreciation 0 1 1 2 1 2 3 4 12 17
Profit before tax 3 3 5 6 8 4 -0 12 -5 -10
Tax % 34% 33% 33% 33% 29% 29% 41% 28% -23%
2 2 3 4 6 3 -0 9 -6 -10
EPS in Rs 2.17 1.43 1.85 2.12 2.26 1.12 -0.09 3.54 -2.29 -3.96
Dividend Payout % 0% 50% 38% 34% 32% 90% -1,170% 42% -44%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -155%
Stock Price CAGR
10 Years: %
5 Years: 20%
3 Years: 46%
1 Year: 68%
Return on Equity
10 Years: %
5 Years: %
3 Years: 1%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2014 Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 7 10 12 14 18 25 25 25 25 26
Reserves 5 3 4 4 51 44 42 64 55 76
3 6 5 5 0 0 0 15 45 50
5 10 14 17 21 20 19 35 33 31
Total Liabilities 20 29 35 40 90 88 85 139 158 184
8 10 9 8 10 15 14 29 62 68
CWIP 0 0 0 0 2 0 0 0 3 4
Investments 0 0 0 0 16 14 10 33 8 24
12 19 26 32 63 59 61 77 85 88
Total Assets 20 29 35 40 90 88 85 139 158 184

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2014 Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
3 5 -3 6 -1 13 -2
-1 -1 9 -4 4 -27 15
-2 -4 -6 -3 -2 14 -14
Net Cash Flow 0 0 -1 -1 1 1 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2014 Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 75 71 79 77 95 112 99 102 73
Inventory Days 122 141 134 175 208 139 140 121 183
Days Payable 77 90 0 0 104 82 77 78 116
Cash Conversion Cycle 120 123 212 251 199 169 161 145 140
Working Capital Days 102 89 86 100 175 152 143 115 135
ROCE % 20% 32% 6% -2% 15% -2%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Apr 2024
68.10% 68.09% 68.11% 68.12% 68.12% 68.12% 68.12% 68.12% 66.16% 66.15% 66.15% 64.45%
0.00% 0.00% 0.00% 0.00% 0.07% 0.00% 0.00% 0.04% 0.02% 0.00% 0.00% 0.00%
0.02% 0.34% 0.30% 0.45% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
31.88% 31.57% 31.59% 31.43% 31.75% 31.88% 31.88% 31.84% 33.83% 33.85% 33.85% 35.55%
No. of Shareholders 6,8427,2557,8178,1497,8667,9567,2337,1077,2857,5897,4357,369

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP